1. Home
  2. AXR vs XGN Comparison

AXR vs XGN Comparison

Compare AXR & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$19.24

Market Cap

127.3M

Sector

Real Estate

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$6.02

Market Cap

138.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
XGN
Founded
1961
2002
Country
United States
United States
Employees
N/A
209
Industry
Homebuilding
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.3M
138.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
AXR
XGN
Price
$19.24
$6.02
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$13.67
AVG Volume (30 Days)
9.3K
320.4K
Earning Date
12-12-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
$45,947,000.00
$63,599,000.00
Revenue This Year
$28.57
$21.76
Revenue Next Year
N/A
$15.63
P/E Ratio
$9.72
N/A
Revenue Growth
N/A
14.08
52 Week Low
$17.60
$2.67
52 Week High
$34.00
$12.23

Technical Indicators

Market Signals
Indicator
AXR
XGN
Relative Strength Index (RSI) 40.04 29.08
Support Level $18.80 $5.74
Resistance Level $19.44 $6.21
Average True Range (ATR) 0.60 0.33
MACD 0.07 0.07
Stochastic Oscillator 35.93 23.26

Price Performance

Historical Comparison
AXR
XGN

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: